Complement fixation is activated through three protease cascade pathways: the classical, the alternative and the mannan-binding lectin pathway 101. All pathways involve the cleavage of complement ...

Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, ...

Researchers at the Tohoku University Graduate School of Medicine have uncovered a key primary step in the hepatic ERK pathway ...

Business leaders from major Hoosier companies say they are trying to navigate the uncertain trade environment created by President Donald Trump’s fluctuating tariff policy by exploring ...

Natural products are among the most promising candidates for the development of new drugs. However, due to their structural complexity, they are often difficult to access.

An elegant screening strategy unveils a molecular actor that connects widespread changes in mRNA processing with a nutrient-sensing protein modification.

CEO Samir Dhir said that the company is pursuing a $34 million pipeline in AI programs with over 100 clients. He brings over three decades of expertise in the GCC ecosystem and consulting, having ...